II

104TH CONGRESS

2D SESSION S. 1897

To amend the Public Health Service Act to revise and extend certain programs relating to the National Institutes of Health, and for other purposes.

IN THE SENATE OF THE UNITED STATES

JUNE 21, 1996

Mrs. KASSEBAUM (for herself, Mr. KENNEDY, Mr. JEFFORDS, Mr. PELL, and

Mr. HATFIELD) introduced the following bill; which was read twice and

referred to the Committee on Labor and Human Resources

A BILL

To amend the Public Health Service Act to revise and extend

certain programs relating to the National Institutes of

Health, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE; REFERENCES; AND TABLE OF

4 CONTENTS

5 (a) SHORT TITLE.—This Act may be cited as the

6 ‘‘National Institutes of Health Revitalization Act of

7 1996’’.

8 (b) REFERENCES.—Whenever in this Act an amend9 ment is expressed in terms of an amendment to a section
2

•S 1897 IS

1 or other provision, the reference shall be considered to be

2 made to a section or other provision of the Public Health

3 Service Act (42 U.S.C. 201 et seq.).

4 (c) TABLE OF CONTENTS.—The table of contents for

5 this Act is as follows:

Sec. 1. Short title; references; and table of contents.

TITLE I—PROVISIONS RELATING TO THE NATIONAL INSTITUTES

OF HEALTH

Sec. 101. Director’s discretionary fund.

Sec. 102. Children’s vaccine initiative.

TITLE II—PROVISIONS RELATING TO THE NATIONAL RESEARCH

INSTITUTES

Sec. 201. Research on osteoporosis, Paget’s disease, and related bone disorders.

Sec. 202. National Human Genome Research Institute.

Sec. 203. Increased amount of grant and other awards.

Sec. 204. Meetings of advisory committees and councils.

Sec. 205. Elimination or modification of reports.

TITLE III—SPECIFIC INSTITUTES AND CENTERS

Subtitle A—National Cancer Institute

Sec. 301. Authorization of appropriations.

Sec. 302. DES study.

Subtitle B—National Heart Lung and Blood Institute

Sec. 311. Authorization of appropriations.

Subtitle C—National Institute of Allergy and Infectious Diseases

Sec. 321. Research and research training regarding tuberculosis.

Sec. 322. Terry Beirn community-based aids research initiative.

Subtitle D—National Institute of Child Health and Human Development

Sec. 331. Research centers for contraception and infertility.

Subtitle E—National Institute on Aging

Sec. 341. Authorization of appropriations.

Subtitle F—National Institute on Alcohol Abuse and Alcoholism

Sec. 351. Authorization of appropriations.

Sec. 352. National alcohol research center.

Subtitle G—National Institute on Drug Abuse

Sec. 361. Authorization of appropriations.
3

•S 1897 IS

Sec. 362. Medication development program.

Sec. 363. Drug abuse research centers.

Subtitle H—National Institute of Mental Health

Sec. 371. Authorization of appropriations.

Subtitle I—National Center for Research Resources

Sec. 381. Authorization of appropriations.

Sec. 382. General clinical research centers.

Sec. 383. Enhancement awards.

Sec. 384. Waiver of limitations.

Subtitle J—National Library of Medicine

Sec. 391. Authorization of appropriations.

Sec. 392. Increasing the cap on grant amounts.

TITLE IV—AWARDS AND TRAINING

Sec. 401. Medical scientist training program.

Sec. 402. Raise in maximum level of loan repayments.

Sec. 403. General loan repayment program.

Sec. 404. Clinical research assistance.

TITLE V—RESEARCH WITH RESPECT TO AIDS

Sec. 501. Comprehensive plan for expenditure of AIDS appropriations.

Sec. 502. Emergency AIDS discretionary fund.

TITLE VI—GENERAL PROVISIONS

Subtitle A—Authority of the Director of NIH

Sec. 601. Authority of the director of NIH.

Subtitle B—Office of Rare Disease Research

Sec. 611. Establishment of office for rare disease research.

Subtitle C—Certain Reauthorizations

Sec. 621. National research service awards.

Sec. 622. National Foundation for Biomedical Research.

Subtitle D—Miscellaneous Provisions

Sec. 631. Establishment of national fund for health research.

Sec. 632. Definition of clinical research.

Sec. 633. Senior Biomedical Research Service.

Subtitle E—Repeals and Conforming Amendments

Sec. 641. Repeals and conforming amendments.
4

•S 1897 IS

1 TITLE I—PROVISIONS RELATING

2 TO THE NATIONAL INSTI3 TUTES OF HEALTH

4 SEC. 101. DIRECTOR’S DISCRETIONARY FUND.

5 Section 402(i)(3) (42 U.S.C. 282(i)(3)) is amended

6 by striking ‘‘$25,000,000’’ and all that follows through

7 the period and inserting ‘‘such sums as may be necessary

8 for each of the fiscal years 1997 through 1999.’’.

9 SEC. 102. CHILDREN’S VACCINE INITIATIVE.

10 Section 404B(c) (42 U.S.C. 283d(c)) is amended by

11 striking ‘‘$20,000,000’’ and all that follows through the

12 period and inserting ‘‘such sums as may be necessary for

13 each of the fiscal years 1997 through 1999.’’.

14 TITLE II—PROVISIONS RELAT15 ING TO THE NATIONAL RE16 SEARCH INSTITUTES

17 SEC. 201. RESEARCH ON OSTEOPOROSIS, PAGET’S DISEASE,

18 AND RELATED BONE DISORDERS.

19 Section 409A(d) (42 U.S.C. 284e(d)) is amended by

20 striking ‘‘$40,000,000’’ and all that follows through the

21 period and inserting ‘‘such sums as may be necessary for

22 each of the fiscal years 1997 through 1999.’’.
5

•S 1897 IS

1 SEC. 202. NATIONAL HUMAN GENOME RESEARCH INSTI2 TUTE.

3 (a) IN GENERAL.—Part C of title IV (42 U.S.C. 285

4 et seq.) is amended by adding at the end thereof the fol5 lowing new subpart:

6 ‘‘Subpart 18—National Human Genome Research

7 Institute

8 ‘‘SEC. 464Z. PURPOSE OF THE INSTITUTE.

9 ‘‘(a) IN GENERAL.—The general purpose of the Na10 tional Human Genome Research Institute is to character11 ize the structure and function of the human genome, in12 cluding the mapping and sequencing of individual genes.

13 Such purpose includes—

14 ‘‘(1) planning and coordinating the research

15 goal of the genome project;

16 ‘‘(2) reviewing and funding research proposals;

17 ‘‘(3) conducting and supporting research train18 ing;

19 ‘‘(4) coordinating international genome re20 search;

21 ‘‘(5) communicating advances in genome science

22 to the public;

23 ‘‘(6) reviewing and funding proposals to address

24 the ethical, legal, and social issues associated with

25 the genome project (including legal issues regarding

26 patents); and
6

•S 1897 IS

1 ‘‘(7) planning and administering intramural,

2 collaborative, and field research to study human ge3 netic disease.

4 ‘‘(b) RESEARCH.—The Director of the Institute may

5 conduct and support research training—

6 ‘‘(1) for which fellowship support is not pro7 vided under section 487; and

8 ‘‘(2) that is not residency training of physicians

9 or other health professionals.

10 ‘‘(c) ETHICAL, LEGAL, AND SOCIAL ISSUES.—

11 ‘‘(1) IN GENERAL.—Except as provided in para12 graph (2), of the amounts appropriated to carry out

13 subsection (a) for a fiscal year, the Director of the

14 Institute shall make available not less than 5 per15 cent of amounts made available for extramural re16 search for carrying out paragraph (6) of such sub17 section.

18 ‘‘(2) NONAPPLICATION.—With respect to pro19 viding funds under subsection (a)(6) for proposals to

20 address the ethical issues associated with the ge21 nome project, paragraph (1) shall not apply for a

22 fiscal year if the Director of the Institute certifies to

23 the Committee on Commerce of the House of Rep24 resentatives, and to the Committee on Labor and

25 Human Resources of the Senate, that the Director
7

•S 1897 IS

1 has determined that an insufficient number of such

2 proposals meet the applicable requirements of sec3 tions 491 and 492.

4 ‘‘(d) TRANSFER.—

5 ‘‘(1) IN GENERAL.—There are transferred to

6 the National Human Genome Research Institute all

7 functions which the National Center for Human Ge8 nome Research exercised before the date of enact9 ment of this subpart, including all related functions

10 of any officer or employee of the National Center for

11 Human Genome Research. The personnel employed

12 in connection with, and the assets, liabilities, con13 tracts, property, records, and unexpended balances

14 of appropriations, authorizations, allocations, and

15 other funds employed, used, held, arising from,

16 available to, or to be made available in connection

17 with the functions transferred under this subsection

18 shall be transferred to the National Human Genome

19 Research Institute.

20 ‘‘(2) LEGAL DOCUMENTS.—All orders, deter21 minations, rules, regulations, permits, agreements,

22 grants, contracts, certificates, licenses, regulations,

23 privileges, and other administrative actions which

24 have been issued, made, granted, or allowed to be25 come effective in the performance of functions which
8

•S 1897 IS

1 are transferred under this subsection shall continue

2 in effect according to their terms until modified, ter3 minated, superseded, set aside, or revoked in accord4 ance with law.

5 ‘‘(3) REFERENCES.—References in any other

6 Federal law, Executive order, rule, regulation, or

7 delegation of authority, or any document of or relat8 ing to the National Center for Human Genome Re9 search shall be deemed to refer to the National

10 Human Genome Research Institute.

11 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There

12 are authorized to be appropriated to carry out this section,

13 such sums as may be necessary for each of the fiscal years

14 1997 through 1999.’’.

15 (b) CONFORMING AMENDMENTS.—

16 (1) Section 401(b) (42 U.S.C. 281(b)) is

17 amended—

18 (A) in paragraph (1), by adding at the end

19 thereof the following new subparagraph:

20 ‘‘(R) The National Human Genome Research

21 Institute.’’; and

22 (B) in paragraph (2)—

23 (i) by striking subparagraph (D); and

24 (ii) by redesignating subparagraph

25 (E) as subparagraph (D).
9

•S 1897 IS

1 (2) Subpart 3 of part E of title IV (42 U.S.C.

2 287c et seq.) is repealed.

3 SEC. 203. INCREASED AMOUNT OF GRANT AND OTHER

4 AWARDS.

5 Section 405(b)(2)(B) (42 U.S.C. 284(b)(2)(B) is

6 amended—

7 (1) in clause (i), by striking ‘‘$50,000’’ and in8 serting ‘‘$100,000’’; and

9 (2) in clause (ii), by striking ‘‘$50,000’’ and in10 serting ‘‘$100,000’’.

11 SEC. 204. MEETINGS OF ADVISORY COMMITTEES AND

12 COUNCILS.

13 (a) IN GENERAL.—Section 406 (42 U.S.C. 284a) is

14 amended—

15 (1) in subsection (e), by striking ‘‘, but at least

16 three times each fiscal year’’; and

17 (2) in subsection (h)(2)—

18 (A) in subparagraph (A)—

19 (i) in clause (iv), by adding ‘‘and’’

20 after the semicolon;

21 (ii) in clause (v), by striking ‘‘; and’’

22 and inserting a period; and

23 (iii) by striking clause (vi); and

24 (B) in subparagraph (B), by striking ‘‘, ex25 cept’’ and all that follows through ‘‘year’’.
10

•S 1897 IS

1 (b) PRESIDENT’S CANCER PANEL.—Section

2 415(a)(3) (42 U.S.C. 285a–4(a)(3)) is amended by strik3 ing ‘‘, but not less often than four times a year’’.

4 (c) INSTITUTE OF DIABETES AND DIGESTIVE AND

5 KIDNEY DISEASES INTERAGENCY COORDINATING COM6 MITTEES.—Section 429(b) (42 U.S.C. 285c–3(b)) is

7 amended by striking ‘‘, but not less often than four times

8 a year’’.

9 (d) INSTITUTE OF ARTHRITIS AND MUSCULO10 SKELETAL AND SKIN DISEASES INTERAGENCY COORDI11 NATING COMMITTEES.—Section 439(b) (42 U.S.C. 285d–

12 4(b)) is amended by striking ‘‘, but not less often than

13 four times a year’’.

14 (e) INSTITUTE ON DEAFNESS AND OTHER COMMU15 NICATION DISORDERS INTERAGENCY COORDINATING

16 COMMITTEES.—Section 464E(d) (42 U.S.C. 285m–5(d))

17 is amended by striking ‘‘, but not less often than four

18 times a year’’.

19 (f) INSTITUTE OF NURSING RESEARCH ADVISORY

20 COUNCIL.—Section 464X(e) (42 U.S.C. 285q–2(e)) is

21 amended by striking ‘‘, but at least three times each fiscal

22 year’’.

23 (g) CENTER FOR RESEARCH RESOURCES ADVISORY

24 COUNCIL.—Section 480(e) (42 U.S.C. 287a(e)) is amend25 ed by striking ‘‘, but at least three times each fiscal year’’.
11

•S 1897 IS

1 (h) APPLICATION OF FACA.—Part B of title IV (42

2 U.S.C. 284 et seq.) is amended by adding at the end there3 of the following new section:

4 ‘‘SEC. 409B. APPLICATION OF FEDERAL ADVISORY COMMIT5 TEE ACT.

6 ‘‘Notwithstanding any other provision of law, the pro7 visions of the Federal Advisory Committee Act (5 U.S.C.

8 Ap. 2) shall not apply to a scientific or technical peer re9 view group, established under this title.’’.

10 SEC. 205. ELIMINATION OR MODIFICATION OF REPORTS.

11 (a) PUBLIC HEALTH SERVICE ACT REPORTS.—The

12 following provisions of the Public Health Service Act are

13 repealed:

14 (1) Section 403 (42 U.S.C. 283) relating to the

15 biennial report of the Director of the National Insti16 tutes of Health to Congress and the President.

17 (2) Subsection (c) of section 439 (42 U.S.C.

18 285d-4(c)) relating to the annual report of the Ar19 thritis and Musculoskeletal Diseases Interagency Co20 ordinating Committee and the annual report of the

21 Skin Diseases Interagency Coordinating Committee.

22 (3) Subsection (j) of section 442 (42 U.S.C.

23 285d-7(j)) relating to the annual report of the Na24 tional Arthritis and Musculoskeletal and Skin Dis25 eases Advisory Board.
12

•S 1897 IS

1 (4) Subsection (b) of section 494A (42 U.S.C.

2 289c–1(b)) relating to the annual report of the Sec3 retary of Health and Human Services on health

4 services research relating to alcohol abuse and alco5 holism, drug abuse, and mental health.

6 (5) Subsection (b) of section 503 (42 U.S.C.

7 290aa–2(b)) relating to the triennial report of the

8 Secretary of Health and Human Services to Con9 gress.

10 (b) REPORT ON DISEASE PREVENTION.—Section

11 402(f)(3) (42 U.S.C. 282(f)(3)) is amended by striking

12 ‘‘annually’’ and inserting ‘‘biennially’’.

13 (c) REPORTS OF THE COORDINATING COMMITTEES

14 ON DIGESTIVE DISEASES, DIABETES MELLITUS, AND

15 KIDNEY, UROLOGIC AND HEMATOLOGIC DISEASES.—Sec16 tion 429 (42 U.S.C. 285c–3) is amended by striking sub17 section (c).

18 (d) REPORT OF THE TASK FORCE ON AGING RE19 SEARCH.—Section 304 of the Home Health Care and Alz20 heimer’s Disease Amendments of 1990 (42 U.S.C. 242q–

21 3) is repealed.

22 (e) SUDDEN INFANT DEATH SYNDROME RE23 SEARCH.—Section 1122 (42 U.S.C. 300c–12) is amend24 ed—

25 (1) in subsection (a)—
13

•S 1897 IS

1 (A) by striking the subsection designation

2 and heading; and

3 (B) by striking ‘‘of the type’’ and all that

4 follows through ‘‘adequate,’’ and insert ‘‘, such

5 amounts each year as will be adequate for re6 search which relates generally to sudden infant

7 death syndrome, including high-risk pregnancy

8 and high-risk infancy research which directly

9 relates to sudden infant death syndrome, and to

10 the relationship of the high-risk pregnancy and

11 high-risk infancy research to sudden infant

12 death syndrome,’’; and

13 (2) by striking subsections (b) and (c).

14 (f) U.S.-JAPAN COOPERATIVE MEDICAL SCIENCE

15 PROGRAM.—Subsection (h) of section 5 of the Inter16 national Health Research Act of 1960 is repealed.

17 (g) CONFORMING AMENDMENTS.—Title IV is amend18 ed—

19 (1) in section 404C(c) (42 U.S.C. 283e(c)), by

20 striking ‘‘included’’ and all that follows through the

21 period and inserting ‘‘made available to the commit22 tee established under subsection (e) and included in

23 the official minutes of the committee’’;
14

•S 1897 IS

1 (2) in section 404E(d)(3)(B) (42 U.S.C.

2 283g(d)(3)(B)), by striking ‘‘for inclusion in the bi3 ennial report under section 403’’;

4 (3) in section 406(g) (42 U.S.C. 284a(g))—

5 (A) by striking ‘‘for inclusion in the bien6 nial report made under section 407’’ and insert7 ing ‘‘as it may determine appropriate’’; and

8 (B) by striking the second sentence;

9 (4) in section 407 (42 U.S.C. 284b)—

10 (A) in the section heading, to read as fol11 lows:

12 ‘‘REPORTS’’; AND

13 (B) by striking ‘‘shall prepare for inclusion

14 in the biennial report made under section 403

15 a biennial’’ and inserting ‘‘may prepare a’’;

16 (5) in section 416(b) (42 U.S.C. 285a–5(b)) by

17 striking ‘‘407’’ and inserting ‘‘402(f)(3)’’;

18 (6) in section 417 (42 U.S.C. 285a–6), by strik19 ing subsection (e);

20 (7) in section 423(b) (42 U.S.C. 285b–6(b)), by

21 striking ‘‘407’’ and inserting ‘‘402(f)(3)’’;

22 (8) by striking section 433 (42 U.S.C. 285c–7);

23 (9) in section 451(b) (42 U.S.C. 285g–3(b)), by

24 striking ‘‘407’’ and inserting ‘‘402(f)(3)’’;

25 (10) in section 452(d) (42 U.S.C. 285g–4(d))—

26 (A) in paragraph (3)—
15

•S 1897 IS

1 (i) in subparagraph (A), by striking

2 ‘‘(A) Not’’ and inserting ‘‘Not’’; and

3 (ii) by striking subparagraph (B); and

4 (B) in the last sentence of paragraph (4),

5 by striking ‘‘contained’’ and all that follows

6 through the period and inserting ‘‘transmitted

7 to the Director of NIH.’’;

8 (11) in section 464I(b) (42 U.S.C. 285n–1(b)),

9 by striking ‘‘407’’ and inserting ‘‘402(f)(3)’’;

10 (12) in section 464M(b) (42 U.S.C. 285o–

11 1)(b)), by striking ‘‘407’’ and inserting ‘‘402(f)(3)’’;

12 (13) in section 464S(b) (42 U.S.C. 285p–1(b)),

13 by striking ‘‘407’’ and inserting ‘‘402(f)(3)’’;

14 (14) in section 464X(g) (42 U.S.C. 285q–2(g))

15 is amended—

16 (A) by striking ‘‘for inclusion in the bien17 nial report made under section 464Y’’ and in18 serting ‘‘as it may determine appropriate’’; and

19 (B) by striking the second sentence;

20 (15) in section 464Y (42 U.S.C. 285q–3)—

21 (A) in the section heading, to read as fol22 lows:

23 ‘‘REPORTS’’; AND

24 (B) by striking ‘‘shall prepare for inclusion

25 in the biennial report made under section 403

26 a biennial’’ and inserting ‘‘may prepare a’’;
16

•S 1897 IS

1 (16) in section 480(g) (42 U.S.C. 287a(g))—

2 (A) by striking ‘‘for inclusion in the bien3 nial report made under section 481’’ and insert4 ing ‘‘as it may determine appropriate’’; and

5 (B) by striking the second sentence;

6 (17) in section 481 (42 U.S.C. 287a–1)—

7 (A) in the section heading, to read as fol8 lows:

9 ‘‘REPORTS’’; AND

10 (B) by striking ‘‘shall prepare for inclusion

11 in the biennial report made under section 403

12 a biennial’’ and inserting ‘‘may prepare a’’;

13 (18) in section 486(d)(5)(B) (42 U.S.C.

14 287d(d)(5)(B)), by striking ‘‘for inclusion in the re15 port required in section 403’’;

16 (19) in section 486B (42 U.S.C. 287d–2) by

17 striking subsection (b) and inserting the following

18 new subsection:

19 ‘‘(b) SUBMISSION.—The Director of the Office shall

20 submit each report prepared under subsection (a) to the

21 Director of NIH.’’; and

22 (20) in section 492B(f) (42 U.S.C. 289a–2(f)),

23 by striking ‘‘for inclusion’’ and all that follows

24 through the period and inserting ‘‘and the Director

25 of NIH.’’.
17

•S 1897 IS

1 TITLE III—SPECIFIC INSTITUTES

2 AND CENTERS

3 Subtitle A—National Cancer

4 Institute

5 SEC. 301. AUTHORIZATION OF APPROPRIATIONS.

6 Section 417B (42 U.S.C. 286a–8) is amended—

7 (1) in subsection (a), by striking

8 ‘‘$2,728,000,000’’ and all that follows through the

9 period and inserting ‘‘$3,000,000,000 for fiscal year

10 1997, and such sums as may be necessary for each

11 of the fiscal years 1998 and 1999.’’;

12 (2) in subsection (b)—

13 (A) in paragraph (1)—

14 (i) in the first sentence of subpara15 graph (A), by striking ‘‘$225,000,000’’

16 and all that follows through the first pe17 riod and inserting ‘‘such sums as may be

18 necessary for each of the fiscal years 1997

19 through 1999.’’; and

20 (ii) in the first sentence of subpara21 graph (B), by striking ‘‘$100,000,000’’

22 and all that follows through the first pe23 riod and inserting ‘‘such sums as may be

24 necessary for each of the fiscal years 1997

25 through 1999.’’; and
18

•S 1897 IS

1 (B) in the first sentence of paragraph (2),

2 by striking ‘‘$75,000,000’’ and all that follows

3 through the first period and inserting ‘‘such

4 sums as may be necessary for each of the fiscal

5 years 1997 through 1999.’’; and

6 (3) in the first sentence of subsection (c), by

7 striking ‘‘$72,000,000’’ and all that follows through

8 the first period and inserting ‘‘such sums as may be

9 necessary for each of the fiscal years 1997 through

10 1999.’’.

11 SEC. 302. DES STUDY.

12 Section 403A(e) (42 U.S.C. 283a(e)) is amended by

13 striking ‘‘1996’’ and inserting ‘‘1999’’.

14 Subtitle B—National Heart Lung

15 and Blood Institute

16 SEC. 311. AUTHORIZATION OF APPROPRIATIONS.

17 Section 425 (42 U.S.C. 285b–8) is amended by strik18 ing ‘‘$1,500,000,000’’ and all that follows through the pe19 riod and inserting ‘‘$1,600,000,000 for fiscal year 1997,

20 and such sums as may be necessary for each of the fiscal

21 years 1998 and 1999.’’.
19

•S 1897 IS

1 Subtitle C—National Institute of

2 Allergy and Infectious Diseases

3 SEC. 321. RESEARCH AND RESEARCH TRAINING REGARD4 ING TUBERCULOSIS.

5 Subpart 6 of part C of title IV is amended in the

6 first section 447(b) (42 U.S.C. 285f–2(b)) by striking

7 ‘‘$50,000,000’’ and all that follows through the first pe8 riod 1998’’ and inserting such sums as may be necessary

9 for each of the fiscal years 1997 through 1999.’’.

10 SEC. 322. TERRY BEIRN COMMUNITY-BASED AIDS RE11 SEARCH INITIATIVE.

12 Section 2313(e) (42 U.S.C. 300cc–13(e)) is amend13 ed—

14 (1) in paragraph (1), by striking ‘‘1996’’ and

15 inserting ‘‘1999’’; and

16 (2) in paragraph (2), by striking ‘‘1996’’ and

17 inserting ‘‘1999’’.

18 Subtitle D—National Institute of

19 Child Health and Human Devel20 opment

21 SEC. 331. RESEARCH CENTERS FOR CONTRACEPTION AND

22 INFERTILITY.

23 Section 452A(g) (42 U.S.C. 285g–5(g)) is amended

24 by striking ‘‘$30,000,000’’ and all that follows through
20

•S 1897 IS

1 the period and inserting ‘‘such sums as may be necessary

2 for each of the fiscal years 1997 through 1999.’’.

3 Subtitle E—National Institute on

4 Aging

5 SEC. 341. AUTHORIZATION OF APPROPRIATIONS.

6 Section 445I (42 U.S.C. 285e–11) is amended by

7 striking ‘‘$500,000,000’’ and all that follows through the

8 period and inserting ‘‘$550,000,000 for fiscal year 1997,

9 and such sums as may be necessary for each of the fiscal

10 years 1998 and 1999.’’.

11 Subtitle F—National Institute on

12 Alcohol Abuse and Alcoholism

13 SEC. 351. AUTHORIZATION OF APPROPRIATIONS.

14 Section 464H(d)(1) (42 U.S.C. 285n(d)(1)) is

15 amended by striking ‘‘300,000,000’’ and all that follows

16 through the period and inserting ‘‘$330,000,000 for fiscal

17 year 1997, and such sums as may be necessary for each

18 of the fiscal years 1998 and 1999.’’.

19 SEC. 352. NATIONAL ALCOHOL RESEARCH CENTER.

20 Section 464J(b) (42 U.S.C. 285n–2(b)) is amend21 ed—

22 (1) by striking ‘‘(b) The’’ and inserting ‘‘(b)(1)

23 The’’;

24 (2) by striking the third sentence; and
21

•S 1897 IS

1 (3) by adding at the end thereof the following

2 new paragraph:

3 ‘‘(2) As used in paragraph (1), the terms ‘construc4 tion’ and ‘cost of construction’ include—

5 ‘‘(A) the construction of new buildings, the ex6 pansion of existing buildings, and the acquisition, re7 modeling, replacement, renovation, major repair (to

8 the extent permitted by regulations), or alteration of

9 existing buildings, including architects’ fees, but not

10 including the cost of the acquisition of land or off11 site improvements; and

12 ‘‘(B) the initial equipping of new buildings and

13 of the expanded, remodeled, repaired, renovated, or

14 altered part of existing buildings; except that

15 such term shall not include the construction or cost of con16 struction of so much of any facility as is used or is to

17 be used for sectarian instruction or as a place for religious

18 worship.’’.

19 Subtitle G—National Institute on

20 Drug Abuse

21 SEC. 361. AUTHORIZATION OF APPROPRIATIONS.

22 Section 464L(d)(1) (42 U.S.C. 285o(d)(1)) is amend23 ed by striking ‘‘$440,000,000’’ and all that follows

24 through the period and inserting ‘‘$480,000,000 for fiscal
22

•S 1897 IS

1 year 1997, and such sums as may be necessary for each

2 of the fiscal years 1998 and 1999.’’.

3 SEC. 362. MEDICATION DEVELOPMENT PROGRAM.

4 Section 464P(e) (42 U.S.C. 285o–4(e)) is amended

5 by striking ‘‘$85,000,000’’ and all that follows through

6 the period and inserting ‘‘such sums as may be necessary

7 for each of the fiscal years 1997 through 1999’’.

8 SEC. 363. DRUG ABUSE RESEARCH CENTERS.

9 Section 464N(b) (42 U.S.C. 285o–2(b)) is amend10 ed—

11 (1) by striking ‘‘(b) The’’ and inserting ‘‘(b)(1)

12 The’’;

13 (2) by striking the last sentence; and

14 (3) by adding at the end thereof the following

15 new paragraph:

16 ‘‘(2) As used in paragraph (1), the terms ‘construc17 tion’ and ‘cost of construction’ include—

18 ‘‘(A) the construction of new buildings, the ex19 pansion of existing buildings, and the acquisition, re20 modeling, replacement, renovation, major repair (to

21 the extent permitted by regulations), or alteration of

22 existing buildings, including architects’ fees, but not

23 including the cost of the acquisition of land or off24 site improvements; and
23

•S 1897 IS

1 ‘‘(B) the initial equipping of new buildings and

2 of the expanded, remodeled, repaired, renovated, or

3 altered part of existing buildings; except that

4 such term does not include the construction or cost of con5 struction of so much of any facility as is used or is to

6 be used for sectarian instruction or as a place for religious

7 worship.’’.

8 Subtitle H—National Institute of

9 Mental Health

10 SEC. 371. AUTHORIZATION OF APPROPRIATIONS.

11 Section 464R(f)(1) (42 U.S.C. 285p(f)(1)) is amend12 ed by striking ‘‘$675,000,000’’ and all that follows

13 through the period and inserting ‘‘$750,000,000 for fiscal

14 year 1997, and such sums as may be necessary for each

15 of the fiscal years 1998 and 1999.’’.

16 Subtitle I—National Center for

17 Research Resources

18 SEC. 381. AUTHORIZATION OF APPROPRIATIONS.

19 (a) GENERAL AUTHORIZATION.—Section 481A(h)

20 (42 U.S.C. 287a–2(h)) is amended by striking

21 ‘‘$150,000,000’’ and all that follows through the period

22 and inserting ‘‘such sums as may be necessary for each

23 of the fiscal years 1997 through 1999.’’.
24

•S 1897 IS

1 (b) RESERVATION FOR CONSTRUCTION OF REGIONAL

2 CENTERS.—Section 481B(a) (42 U.S.C. 287a–3(a)) is

3 amended—

4 (1) by striking ‘‘shall’’ and inserting ‘‘may’’;

5 (2) by striking ‘‘1994 through 1996’’ and in6 serting ‘‘1997 through 1999’’; and

7 (3) by striking ‘‘$5,000,000’’ and inserting

8 ‘‘such sums as may be necessary for each such fiscal

9 year’’.

10 SEC. 382. GENERAL CLINICAL RESEARCH CENTERS.

11 Part B of title IV (42 U.S.C. 284 et seq.), as amend12 ed by section 205(h), is further amended by adding at the

13 end thereof the following new section:

14 ‘‘SEC. 409C. GENERAL CLINICAL RESEARCH CENTERS.

15 ‘‘(a) GRANTS.—The Director of the National Center

16 for Research Resources shall award grants for the estab17 lishment of general clinical research centers to provide the

18 infrastructure for clinical research including clinical re19 search training and career enhancement. Such centers

20 shall support clinical studies and career development in

21 all settings of the hospital or academic medical center in22 volved.

23 ‘‘(b) ACTIVITIES.—In carrying out subsection (a), the

24 Director of NIH shall expand the activities of the general
25

•S 1897 IS

1 clinical research centers through the increased use of tele2 communications and telemedicine initiatives.

3 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There

4 are authorized to be appropriated to make grants under

5 subsection (a), such sums as may be necessary for each

6 of the fiscal years 1996 and 1999.’’.

7 SEC. 383. ENHANCEMENT AWARDS.

8 Part B of title IV (42 U.S.C. 284 et seq.), as amend9 ed by sections 205(h) and 382, is further amended by add10 ing at the end thereof the following new section:

11 ‘‘SEC. 409D. ENHANCEMENT AWARDS.

12 ‘‘(a) CLINICAL RESEARCH CAREER ENHANCEMENT

13 AWARD.—

14 ‘‘(1) IN GENERAL.—The Director of the Na15 tional Center for Research Resources shall make

16 grants (to be referred to as ‘clinical research career

17 enhancement awards’) to support individual careers

18 in clinical research.

19 ‘‘(2) APPLICATIONS.—An application for a

20 grant under this subsection shall be submitted by an

21 individual scientist at such time as the Director may

22 require.

23 ‘‘(3) LIMITATIONS.—The amount of a grant

24 under this subsection shall not exceed $130,000 per

25 year per grant. Grants shall be for terms of 5 years.
26

•S 1897 IS

1 The Director shall award not more than 20 grants

2 in the first fiscal year in which grants are awarded

3 under this subsection. The total number of grants

4 awarded under this subsection for the first and sec5 ond fiscal years in which grants such are awarded

6 shall not exceed 40 grants.

7 ‘‘(4) AUTHORIZATION OF APPROPRIATIONS.—

8 There are authorized to be appropriated to make

9 grants under paragraph (1), such sums as may be

10 necessary for each of the fiscal years 1997 through

11 1999.

12 ‘‘(b) INNOVATIVE MEDICAL SCIENCE AWARD.—

13 ‘‘(1) IN GENERAL.—The Director of the Na14 tional Center for Research Resources shall make

15 grants (to be referred to as ‘innovative medical

16 science awards’) to support individual clinical re17 search projects.

18 ‘‘(2) APPLICATIONS.—An application for a

19 grant under this subsection shall be submitted by an

20 individual scientist at such time as the Director re21 quires.

22 ‘‘(3) LIMITATIONS.—The amount of a grant

23 under this subsection shall not exceed $100,000 per

24 year per grant.
27

•S 1897 IS

1 ‘‘(4) AUTHORIZATION OF APPROPRIATIONS.—

2 There are authorized to be appropriated to make

3 grants under paragraph (1), such sums as may be

4 necessary for each of the fiscal years 1997 through

5 1999.

6 ‘‘(c) PEER REVIEW.—The Director of NIH, in co7 operation with the Director of the National Center for Re8 search Resources, shall establish peer review mechanisms

9 to evaluate applications for clinical research fellowships,

10 clinical research career enhancement awards, and innova11 tive medical science award programs. Such review mecha12 nisms shall include individuals who are exceptionally quali13 fied to appraise the merits of potential clinical research

14 trainees.’’.

15 SEC. 384. WAIVER OF LIMITATIONS.

16 Section 481A (42 U.S.C. 287a–2) is amended—

17 (1) in subsection (b)(3)(A), by striking ‘‘9’’ and

18 inserting ‘‘12’’;

19 (2) in subsection (e)—

20 (A) in paragraph (1)—

21 (i) in subparagraph (A), by striking

22 ‘‘50’’ and inserting ‘‘40’’; and

23 (ii) in subparagraph (B), by striking

24 ‘‘40’’ and inserting ‘‘30’’; and
28

•S 1897 IS

1 (B) in paragraph (4), by striking ‘‘for ap2 plicants meeting the conditions described in

3 paragraphs (1) and (2) of subsection (c)’’; and

4 (3) in subsection (h), by striking

5 $150,000,000’’ and all that follows through ‘‘1996’’

6 and inserting ‘‘such sums as may be necessary for

7 each of the fiscal years 1997 through 1999’’.

8 Subtitle J—National Library of

9 Medicine

10 SEC. 391. AUTHORIZATION OF APPROPRIATIONS.

11 Section 468(a) (42 U.S.C. 286a–2(a)) is amended by

12 striking ‘‘$150,000,000’’ and all that follows through the

13 period and inserting ‘‘$160,000,000 for fiscal year 1997,

14 and such sums as may be necessary for each of the fiscal

15 years 1998 and 1999.’’.

16 SEC. 392. INCREASING THE CAP ON GRANT AMOUNTS.

17 Section 474(b)(2) (42 U.S.C. 286b–5(b)(2)) is

18 amended by striking ‘‘$1,000,000’’ and inserting

19 ‘‘$1,250,000’’.

20 TITLE IV—AWARDS AND

21 TRAINING

22 SEC. 401. MEDICAL SCIENTIST TRAINING PROGRAM.

23 (a) EXPANSION OF PROGRAM.—Notwithstanding any

24 other provision of law, the Secretary of Health and

25 Human Services, acting through the Director of the Na-
29

•S 1897 IS

1 tional Institutes of Health, shall expand the Medical Sci2 entist Training Program to include fields that will contrib3 ute to training clinical investigators in the skills of per4 forming patient-oriented clinical research.

5 (b) DESIGNATION OF SLOTS.—In carrying out sub6 section (a), the Director of the National Institutes of

7 Health shall designate a specific percentage of positions

8 under the Medical Scientist Training Program for use

9 with respect to the pursuit of a Ph.D. degree in the dis10 ciplines of economics, epidemiology, public health, bio11 engineering, biostatistics and bioethics, and other fields

12 determined appropriate by the Director.

13 SEC. 402. RAISE IN MAXIMUM LEVEL OF LOAN REPAY14 MENTS.

15 (a) REPAYMENT PROGRAMS WITH RESPECT TO

16 AIDS.—Section 487A (42 U.S.C. 288–1) is amended—

17 (1) in subsection (a), by striking ‘‘$20,000’’

18 and inserting ‘‘$35,000’’; and

19 (2) in subsection (c), by striking ‘‘1996’’ and

20 inserting ‘‘1999’’.

21 (b) REPAYMENT PROGRAMS WITH RESPECT TO CON22 TRACEPTION AND INFERTILITY.—Section 487B(a) (42

23 U.S.C. 288–2(a)) is amended by striking ‘‘$20,000’’ and

24 inserting ‘‘$35,000’’.
30

•S 1897 IS

1 (c) REPAYMENT PROGRAMS WITH RESPECT TO RE2 SEARCH GENERALLY.—Section 487C(a)(1) (42 U.S.C.

3 288–3(a)(1)) is amended by striking ‘‘$20,000’’ and in4 serting ‘‘$35,000’’.

5 (d) REPAYMENT PROGRAMS WITH RESPECT TO

6 CLINICAL RESEARCHERS FROM DISADVANTAGED BACK7 GROUNDS.—Section 487E(a) (42 U.S.C. 288–5(a)) is

8 amended—

9 (1) in paragraph (1), by striking ‘‘$20,000’’

10 and inserting ‘‘$35,000’’; and

11 (2) in paragraph (3), by striking ‘‘338C’’ and

12 inserting ‘‘338B, 338C’’.

13 SEC. 403. GENERAL LOAN REPAYMENT PROGRAM.

14 Part G of title IV (42 U.S.C. 288 et seq.) is amended

15 by inserting after section 487E, the following new section:

16 ‘‘SEC. 487F. GENERAL LOAN REPAYMENT PROGRAM.

17 ‘‘(a) ESTABLISHMENT.—

18 ‘‘(1) IN GENERAL.—The Secretary, acting

19 through the Director of NIH, shall carry out a pro20 gram of entering into agreements with appropriately

21 qualified health professionals under which such

22 health professionals agree to conduct research with

23 respect to the areas identified under paragraph (2)

24 in consideration of the Federal Government agreeing

25 to repay, for each year of such service, not more
31

•S 1897 IS

1 than $35,000 of the principal and interest of the

2 educational loans of such health professionals.

3 ‘‘(2) RESEARCH AREAS.—In carrying out the

4 program under paragraph (1), the Director of NIH

5 shall annually identify areas of research for which

6 loan repayments made be awarded under paragraph

7 (1).

8 ‘‘(3) TERM OF AGREEMENT.—A loan repayment

9 agreement under paragraph (1) shall be for a mini10 mum of two years.

11 ‘‘(b) APPLICABILITY OF CERTAIN PROVISIONS.—

12 With respect to the National Health Service Corps Loan

13 Repayment Program established in subpart III of part D

14 of title III, the provisions of such subpart shall, except

15 as inconsistent with subsection (a) of this section, apply

16 to the program established in such subsection (a) in the

17 same manner and to the same extent as such provisions

18 apply to the National Health Service Corps Loan Repay19 ment Program established in such subpart.

20 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—For the

21 purpose of carrying out this section, there are authorized

22 to be appropriated such sums as may be necessary for

23 each of the fiscal years 1997 through 1999.’’.
32

•S 1897 IS

1 SEC. 404. CLINICAL RESEARCH ASSISTANCE.

2 (a) NATIONAL RESEARCH SERVICE AWARDS.—Sec3 tion 487(a)(1)(C) (42 U.S.C. 288(a)(1)(C)) is amended—

4 (1) by striking ‘‘50 such’’ and inserting ‘‘100

5 such’’; and

6 (2) by striking ‘‘1996’’ and inserting ‘‘1999’’.

7 (b) LOAN REPAYMENT PROGRAM.—Section 487E

8 (42 U.S.C. 288–5) is amended—

9 (1) in the section heading, by striking ‘‘FROM

10 DISADVANTAGED BACKGROUNDS’’;

11 (2) in subsection (a)(1), by striking ‘‘who are

12 from disadvantaged backgrounds’’;

13 (3) in subsection (b)—

14 (A) by striking ‘‘Amounts’’ and inserting

15 the following:

16 ‘‘(1) IN GENERAL.—Amounts’’; and

17 (B) by adding at the end thereof the fol18 lowing new paragraph:

19 ‘‘(2) DISADVANTAGED BACKGROUNDS SET20 ASIDE.—In carrying out this section, the Secretary

21 shall ensure that not less than 50 percent of the

22 amounts appropriated for a fiscal year are used for

23 contracts involving those appropriately qualified

24 health professionals who are from disadvantaged

25 backgrounds.’’; and
33

•S 1897 IS

1 (4) by adding at the end thereof the following

2 new subsections:

3 ‘‘(c) CLINICAL RESEARCH TRAINING POSITION.—A

4 position shall be considered a clinical research training po5 sition under subsection (a)(1) if such position involves an

6 individual serving in a general clinical research center or

7 other organizations and institutions determined to be ap8 propriate by the Director of NIH, or a physician receiving

9 a clinical research career enhancement award or NIH in10 tramural research fellowship.

11 ‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—There

12 are authorized to be appropriated to carry out this section

13 such sums as may be necessary for each fiscal year.’’.

14 TITLE V—RESEARCH WITH

15 RESPECT TO AIDS

16 SEC. 501. COMPREHENSIVE PLAN FOR EXPENDITURE OF

17 AIDS APPROPRIATIONS.

18 Section 2353(d)(1) (42 U.S.C. 300cc–40b(d)(1)) is

19 amended by striking ‘‘through 1996’’ and inserting

20 ‘‘through 1999’’.

21 SEC. 502. EMERGENCY AIDS DISCRETIONARY FUND.

22 Section 2356(g)(1) (42 U.S.C. 300cc–43(g)(1)) is

23 amended by striking ‘‘$100,000,000’’ and all that follows

24 through the period and inserting ‘‘such sums as may be

25 necessary for each of the fiscal years 1997 through 1999’’.
34

•S 1897 IS

1 TITLE VI—GENERAL

2 PROVISIONS

3 Subtitle A—Authority of the

4 Director of NIH

5 SEC. 601. AUTHORITY OF THE DIRECTOR OF NIH.

6 Section 402(b) (42 U.S.C. 282(b)) is amended—

7 (1) in paragraph (11), by striking ‘‘and’’ at the

8 end thereof;

9 (2) in paragraph (12), by striking the period

10 and inserting a semicolon; and

11 (3) by adding after paragraph (12), the follow12 ing new paragraphs:

13 ‘‘(13) may conduct and support research train14 ing—

15 ‘‘(A) for which fellowship support is not

16 provided under section 487; and

17 ‘‘(B) which does not consist of residency

18 training of physicians or other health profes19 sionals; and

20 ‘‘(14) may appoint physicians, dentists, and

21 other health care professionals, subject to the provi22 sions of title 5, United States Code, relating to ap23 pointments and classifications in the competitive

24 service, and may compensate such professionals sub-
35

•S 1897 IS

1 ject to the provisions of chapter 74 of title 38, Unit2 ed States Code.’’.

3 Subtitle B—Office of Rare Disease

4 Research

5 SEC. 611. ESTABLISHMENT OF OFFICE FOR RARE DISEASE

6 RESEARCH.

7 Part A of title IV of the Public Health Service Act

8 (42 U.S.C. 281 et seq.) is amended by adding at the end

9 thereof the following new section:

10 ‘‘SEC. 404F. OFFICE FOR RARE DISEASE RESEARCH.

11 ‘‘(a) ESTABLISHMENT.—There is established within

12 the Office of the Director of the National Institutes of

13 Health an office to be known as the Office for Rare Dis14 ease Research (in this section referred to as the ‘Office’).

15 The Office shall be headed by a director, who shall be ap16 pointed by the Director of the National Institutes of

17 Health.

18 ‘‘(b) PURPOSE.—The purpose of the Office is to pro19 mote and coordinate the conduct of research on rare dis20 eases through a strategic research plan and to establish

21 and manage a rare disease research clinical database.

22 ‘‘(c) ADVISORY COUNCIL.—The Secretary shall es23 tablish an advisory council for the purpose of providing

24 advice to the director of the Office concerning carrying

25 out the strategic research plan and other duties under this
36

•S 1897 IS

1 section. Section 222 shall apply to such council to the

2 same extent and in the same manner as such section ap3 plies to committees or councils established under such sec4 tion.

5 ‘‘(d) DUTIES.—In carrying out subsection (b), the di6 rector of the Office shall—

7 ‘‘(1) develop a comprehensive plan for the con8 duct and support of research on rare diseases;

9 ‘‘(2) coordinate and disseminate information

10 among the institutes and the public on rare diseases;

11 ‘‘(3) support research training and encourage

12 the participation of a diversity of individuals in the

13 conduct of rare disease research;

14 ‘‘(4) identify projects or research on rare dis15 eases that should be conducted or supported by the

16 National Institutes of Health;

17 ‘‘(5) develop and maintain a central database

18 on current government sponsored clinical research

19 projects for rare diseases;

20 ‘‘(6) determine the need for registries of re21 search subjects and epidemiological studies of rare

22 disease populations; and

23 ‘‘(7) prepare biennial reports on the activities

24 carried out or to be carried out by the Office and
37

•S 1897 IS

1 submit such reports to the Secretary and the Con2 gress.’’.

3 Subtitle C—Certain

4 Reauthorizations

5 SEC. 621. NATIONAL RESEARCH SERVICE AWARDS.

6 Section 487(d) (42 U.S.C. 288(d)) is amended by

7 striking ‘‘$400,000,000’’ and all that follows through the

8 first period and inserting ‘‘such sums as may be necessary

9 for each of the fiscal years 1997 through 1999.’’.

10 SEC. 622. NATIONAL FOUNDATION FOR BIOMEDICAL RE11 SEARCH.

12 Section 499(m)(1) (42 U.S.C. 290b(m)(1)) is amend13 ed by striking ‘‘an aggregate’’ and all that follows through

14 the period and inserting ‘‘such sums as may be necessary

15 for each of the fiscal years 1997 through 1999’’.

16 Subtitle D—Miscellaneous

17 Provisions

18 SEC. 631. ESTABLISHMENT OF NATIONAL FUND FOR

19 HEALTH RESEARCH.

20 Part A of title IV (42 U.S.C. 281 et seq.), as amend21 ed by section 611, is further amended by adding at the

22 end thereof the following new section:
38

•S 1897 IS

1 ‘‘SEC. 404G. ESTABLISHMENT OF NATIONAL FUND FOR

2 HEALTH RESEARCH.

3 ‘‘(a) ESTABLISHMENT.—There is established in the

4 Treasury of the United States a fund, to be known as the

5 ‘National Fund for Health Research’ (hereafter in this

6 section referred to as the ‘Fund’), consisting of such

7 amounts as are transferred to the Fund and any interest

8 earned on investment of amounts in the Fund.

9 ‘‘(b) OBLIGATIONS FROM FUND.—

10 ‘‘(1) IN GENERAL.—Subject to the provisions of

11 paragraph (2), with respect to the amounts made

12 available in the Fund in a fiscal year, the Secretary

13 shall distribute all of such amounts during any fiscal

14 year to research institutes and centers of the Na15 tional Institutes of Health in the same proportion to

16 the total amount received under this section, as the

17 amount of annual appropriations under appropria18 tions Acts for each member institute and centers for

19 the fiscal year bears to the total amount of appro20 priations under appropriations Acts for all research

21 institutes and centers of the National Institutes of

22 Health for the fiscal year.

23 ‘‘(2) TRIGGER AND RELEASE OF MONIES.—No

24 expenditure shall be made under paragraph (1) dur25 ing any fiscal year in which the annual amount ap26 propriated for the National Institutes of Health is
39

•S 1897 IS

1 less than the amount so appropriated for the prior

2 fiscal year.’’.

3 SEC. 632. DEFINITION OF CLINICAL RESEARCH.

4 Part A of title V (42 U.S.C. 281 et seq.) as amended

5 by sections 611 and 631, is further amended by adding

6 at the end thereof the following new section:

7 ‘‘SEC. 404H. DEFINITION OF CLINICAL RESEARCH.

8 ‘‘As used in this title, the term ‘clinical research’

9 means patient oriented clinical research conducted with

10 human subjects, or research on the causes and con11 sequences of disease in human populations, or on material

12 of human origin (such as tissue specimens and cognitive

13 phenomena) for which an investigator or colleague directly

14 interacts with human subjects in an outpatient or inpa15 tient setting to clarify a problem in human physiology,

16 pathophysiology, or disease, epidemiologic or behavioral

17 studies, outcomes research, or health services research.’’.

18 SEC. 633. SENIOR BIOMEDICAL RESEARCH SERVICE.

19 Section 228 (42 U.S.C. 237) is amended by adding

20 at the end thereof the following new subsection:

21 ‘‘(h) Notwithstanding any other provision of law, the

22 Secretary shall be treated as a non-profit entity for the

23 purposes of making contributions to the retirement sys24 tems of appointees under this section in a manner that

25 will permit such appointees to continue to be fully covered
40

•S 1897 IS

1 under the retirement systems that such appointees were

2 members of immediately prior to their appointment under

3 this section.’’.

4 Subtitle E—Repeals and

5 Conforming Amendments

6 SEC. 641. REPEALS AND CONFORMING AMENDMENTS.

7 (a) RENAMING OF DIVISION OF RESEARCH RE8 SOURCES.—Section 403(5) (42 U.S.C. 283(5)) is amended

9 by striking ‘‘Division of Research Resources’’ and insert10 ing ‘‘National Center for Research Resources’’.

11 (b) RENAMING OF NATIONAL CENTER FOR NURSING

12 RESEARCH.—

13 (1) Section 403(5) (42 U.S.C. 283(5)) is

14 amended by striking ‘‘National Center for Nursing

15 Research’’ and inserting ‘‘National Institute of

16 Nursing Research’’.

17 (2) Section 408(a)(2) (42 U.S.C. 284c(a)(2)) is

18 amended by striking ‘‘National Center for Nursing

19 Research’’ and inserting ‘‘National Institute of

20 Nursing Research’’.

21 (c) RENAMING OF CHIEF MEDICAL DIRECTOR FOR

22 VETERANS AFFAIRS.—

23 (1) Section 406 (42 U.S.C. 284a) is amended—

24 (A) in subsection (b)(2)(A), by striking

25 ‘‘Chief Medical Director of the Department of
41

•S 1897 IS

1 Veterans Affairs or the Chief Dental Director

2 of the Department of Veterans Affairs’’ and in3 serting ‘‘Under Secretary for Health of the De4 partment of Veterans Affairs’’; and

5 (B) in subsection (h)(2)(A)(v) by striking

6 ‘‘Chief Medical Director of the Department of

7 Veterans Affairs,’’ and inserting ‘‘Under Sec8 retary for Health of the Department of Veter9 ans Affairs’’.

10 (2) Section 424(c)(3)(B)(x) (42 U.S.C. 285b–

11 7(c)(3)(B)(x)) is amended by striking ‘‘Chief Medi12 cal Director of the Veterans’ Administration’’ and

13 inserting ‘‘Under Secretary for Health of the De14 partment of Veterans Affairs’’.

15 (3) Section 429(b) (42 U.S.C. 285c–3(b)) is

16 amended by striking ‘‘Chief Medical Director of the

17 Veterans’ Administration’’ and inserting ‘‘Under

18 Secretary for Health of the Department of Veterans

19 Affairs’’.

20 (4) Section 430(b)(2)(A)(i) (42 U.S.C. 285c–

21 4(b)(2)(A)(i)) is amended by striking ‘‘Chief Medical

22 Director of the Department of Veterans Affairs’’

23 and inserting ‘‘Under Secretary for Health of the

24 Department of Veterans Affairs’’.
42

•S 1897 IS

1 (5) Section 439(b) (42 U.S.C. 285d–4(b)) is

2 amended by striking ‘‘Chief Medical Director of the

3 Department of Veterans Affairs’’ and inserting

4 ‘‘Under Secretary for Health of the Department of

5 Veterans Affairs’’.

6 (6) Section 452(f)(3)(B)(ix) (42 U.S.C. 285g–

7 4(f)(3)(B)(ix)) is amended by striking ‘‘Chief Medi8 cal Director of the Department of Veterans Affairs’’

9 and inserting ‘‘Under Secretary for Health of the

10 Department of Veterans Affairs’’.

11 (7) Section 466(a)(1)(B) (42 U.S.C.

12 286a(a)(1)(B)) is amended by striking ‘‘Chief Medi13 cal Director of the Department of Veterans Affairs’’

14 and inserting ‘‘Under Secretary for Health of the

15 Department of Veterans Affairs’’.

16 (8) Section 480(b)(2)(A) (42 U.S.C.

17 287a(b)(2)(A)) is amended by striking ‘‘Chief Medi18 cal Director of the Department of Veterans Affairs’’

19 and inserting ‘‘Under Secretary for Health of the

20 Department of Veterans Affairs’’.

21 (b) ADVISORY COUNCILS.—Section 406(h) (42

22 U.S.C. 284a(h)) is amended—

23 (1) by striking paragraph (1); and

24 (2) in paragraph (2)—
43

•S 1897 IS

1 (A) by striking ‘‘(2)(A) The’’ and inserting

2 ‘‘(1) The’’;

3 (B) by redesignating subparagraph (B) as

4 paragraph (2); and

5 (C) by redesignating clauses (i) through

6 (vi) of paragraph (1) (as so redesignated) as

7 subparagraphs (A) through (F), respectively.

8 (c) DIABETES AND DIGESTIVE AND KIDNEY DIS9 ORDERS ADVISORY BOARDS.—Section 430 (42 U.S.C.

10 285c–4) is repealed.

11 (d) NATIONAL ARTHRITIS AND MUSCULOSKELETAL

12 AND SKIN DISEASES ADVISORY BOARD.—Section 442 (42

13 U.S.C. 285d–7) is repealed.

14 (e) RESEARCH CENTERS REGARDING CHRONIC FA15 TIGUE SYNDROME.—Subpart 6 of part C of title IV (42

16 U.S.C. 285f et seq.) is amended by redesignating the sec17 ond section 447 (42 U.S.C. 285f–1) as section 447A.

18 (f) NATIONAL INSTITUTE ON DEAFNESS ADVISORY

19 BOARD.—Section 464D (42 U.S.C. 285m–4) is repealed.

20 (g) BIOMEDICAL AND BEHAVIORAL RESEARCH PER21 SONNEL STUDY.—Section 489 (42 U.S.C. 288b) is

22 amended—

23 (1) by striking subsections (b); and

24 (2) by redesignating subsection (c) as sub25 section (b).
44

•S 1897 IS

1 (h) NATIONAL COMMISSION ON ALCOHOLISM AND

2 OTHER ALCOHOL-RELATED PROBLEMS.—Section 18 of

3 the Comprehensive Alcohol Abuse and Alcoholism Preven4 tion, Treatment, and Rehabilitation Act Amendments of

5 1979 (42 U.S.C. 4541 note) is repealed.

6 (i) ADVISORY COUNCIL ON HAZARDOUS SUBSTANCES

7 RESEARCH AND TRAINING.—Section 311(a) of the Com8 prehensive Environmental Response, Compensation and

9 Liability Act of 1980 (42 U.S.C. 9660(a)) is amended—

10 (1) by striking paragraph (5); and

11 (2) in the last sentence of paragraph (6), by

12 striking ‘‘the relevant Federal agencies referred to in

13 subparagraph (A) of paragraph (5)’’ and inserting

14 ‘‘relevant Federal agencies’’.

Æ